Abilita Therapeutics, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
Abilita Therapeutics, Inc. is a biotechnology company focused on expanding the druggable landscape for multi-span membrane proteins, including GPCRs, transporters, and ion channels. Its work centers on building a pipeline of high-value assets aimed at discovering and developing antibody therapeutics that target these challenging membrane proteins. The company operates from San Diego, California, and has a presence in the biotech research sector that seeks to address unmet therapeutic needs through novel targets. Founded and operating in the biotechnology research industry, Abilita Therapeutics positions itself as a leader in membrane protein-targeted therapeutics, pursuing first- and best-in-class antibody modalities. The organization aims to connect with collaborators and stakeholders within the broader pharmaceutical and biomedical community as it advances its membrane protein programs from discovery toward development. The most recent public developments include executive appointments signaling organizational expansion aligned with its strategic mission, based in San Diego.
1-888-653-2347 
support@leadiq.com 
